Mibenratide, a small cyclic peptide, is an adrenergic β1 receptor antagonist.
CAT No: R2071
CAS No:1239011-83-6
Synonyms/Alias:Mibenratide;Mibenratide [INN];mibenratida;1239011-83-6;UNII-P1T1143877;P1T1143877;JNJ-54452840;MIBENRATIDE [WHO-DD];mibenratidum;CHEMBL4297617;DTXSID501031265;DA-55466;Q27286014;Cyclo(L-alanyl-L-arginyl-L-arginyl-L-cysteinyl-L-tyrosyl-L-asparaginyl-L-alpha-aspartyl-L-prolyl-L-lysyl-L-cysteinyl-L-seryl-L-alpha-aspartyl-L-phenylalanyl-L-valyl-L-glutaminyl-L-alanyl-L-alpha-aspartyl-L-alpha-glutamyl), cyclic (4-->10)-disulfide;
Chemical Name:3-[(1R,4S,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R,40S,43S,49S,52S,55S)-40-(4-aminobutyl)-52-(2-amino-2-oxoethyl)-22-(3-amino-3-oxopropyl)-28-benzyl-4,7-bis(3-carbamimidamidopropyl)-16,31,49-tris(carboxymethyl)-34-(hydroxymethyl)-55-[(4-hydroxyphenyl)methyl]-10,19-dimethyl-3,6,9,12,15,18,21,24,27,30,33,36,39,42,48,51,54,57-octadecaoxo-25-propan-2-yl-59,60-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,47,50,53,56-octadecazatricyclo[35.20.4.043,47]henhexacontan-13-yl]propanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.